Baxter International Inc. [NYSE: BAX] price surged by 7.45 percent to reach at $4.07. The company report on September 7, 2022 that Baxter to Host Third-Quarter 2022 Financial Results Conference Call for Investors.
China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal
Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.
Simply click here and the name & trading symbol are yours.
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2022 financial results on Thursday, October 27, 2022 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/EmxweYhQ to pre-register for the call and receive the call information.
This call is also being webcast and can be accessed through Baxter’s website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter’s permission.
A sum of 6328369 shares traded at recent session while its average daily volume was at 3.11M shares. Baxter International Inc. shares reached a high of $58.89 and dropped to a low of $54.505 until finishing in the latest session at $58.73.
The one-year BAX stock forecast points to a potential upside of 19.38. The average equity rating for BAX stock is currently 2.10, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Baxter International Inc. [BAX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BAX shares is $72.85 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BAX stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Baxter International Inc. shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on June 24, 2022. While these analysts kept the previous recommendation, Goldman dropped their target price from $88 to $77. The new note on the price target was released on April 04, 2022, representing the official price target for Baxter International Inc. stock. Previously, the target price had yet another raise to $100, while BofA Securities analysts kept a Buy rating on BAX stock. On February 18, 2022, analysts decreased their price target for BAX shares from 95 to 93.
The Average True Range (ATR) for Baxter International Inc. is set at 1.65, with the Price to Sales ratio for BAX stock in the period of the last 12 months amounting to 2.10. The Price to Book ratio for the last quarter was 3.34, with the Price to Cash per share for the same quarter was set at 3.64. Price to Free Cash Flow for BAX in the course of the last twelve months was 53.05 with Quick ratio for the last quarter at 1.30.
BAX Stock Performance Analysis:
Baxter International Inc. [BAX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.98. With this latest performance, BAX shares dropped by -1.64% in over the last four-week period, additionally sinking by -27.00% over the last 6 months – not to mention a drop of -29.54% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BAX stock in for the last two-week period is set at 48.11, with the RSI for the last a single of trading hit 52.56, and the three-weeks RSI is set at 45.37 for Baxter International Inc. [BAX]. The present Moving Average for the last 50 days of trading for this stock 61.57, while it was recorded at 56.76 for the last single week of trading, and 74.66 for the last 200 days.
Insight into Baxter International Inc. Fundamentals:
Baxter International Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 2.00.
BAX Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BAX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Baxter International Inc. go to 8.41%.
Baxter International Inc. [BAX] Insider Position Details
There are presently around $25,374 million, or 89.10% of BAX stock, in the hands of institutional investors. The top three institutional holders of BAX stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 61,887,205, which is approximately 11.368% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 40,792,403 shares of the stock with an approximate value of $2.4 billion in BAX stocks shares; and VANGUARD GROUP INC, currently with $2.39 billion in BAX stock with ownership of nearly 2.021% of the company’s market capitalization.
Positions in Baxter International Inc. stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 419 institutional holders increased their position in Baxter International Inc. [NYSE:BAX] by around 30,097,964 shares. Additionally, 554 investors decreased positions by around 28,613,284 shares, while 245 investors held positions by with 373,327,528 shares. The mentioned changes placed institutional holdings at 432,038,776 shares, according to the latest SEC report filing. BAX stock had 71 new institutional investments in for a total of 2,261,304 shares, while 132 institutional investors sold positions of 4,328,621 shares during the same period.